通过网络毒理学和分子对接,探索双甲对心血管疾病影响的机制
Lina Xie1, Bingwu Huang2, Xuyong Zhao3
1Department of Neurosurgery, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People's Hospital, China.
Heliyon
|May 30, 2024
概括
双甲 (BPA) 暴露与心血管疾病 (CVD) 有关. 网络毒理学确定了关键基因 (ESR1,PPARG,PTGS2) 和涉及BPA对心血管疾病有毒作用的途径,为药物发现提供了洞察力.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 心血管研究研究心血管研究
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 双甲 (BPA),一种内分泌干扰化学物质 (EDC),与心血管疾病的进展有关.
- 了解BPA在心血管疾病中的分子毒性至关重要.
研究的目的:
- 为了阐明BPA诱导的心血管毒性的分子机制.
- 确定受BPA暴露影响的关键分子标和途径.
- 探索网络毒理学和分子对接,以调查环境污染物对心血管疾病的影响.
主要方法:
- 使用STRING和Cytoscape的网络毒理学方法.
- 从ChEMBL,DrugBank和OMIM数据库中确定了27个潜在的目标.
- 基因本体学和KEGG通路丰富分析通过WebGestalt.
- 分子对接以评估BPA与核心目标的结合亲和力.
主要成果:
- 确定ESR1,PPARG和PTGS2作为BPA诱导心血管疾病中的中心基因.
- 揭示了包括信号传递,炎症和上腺体信号传递在内的途径的参与.
- 通过分子对接,证明了BPA与ESR1,PPARG和PTGS2的强烈结合.
结论:
- 建立了BPA在心血管疾病中的分子毒性理论框架.
- 引入了网络毒理学,作为研究环境污染物和心血管疾病的创新方法.
- 提供了针对EDC相关心血管疾病的药物发现的基础.
相关概念视频
Toxic Reactions: Overview
969
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
969
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Mechanistic Models: Overview of Compartment Models
80
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
80


